Log in to save to my catalogue

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_851268774

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

About this item

Full title

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Publisher

Atlanta: Wiley Subscription Services, Inc

Journal title

CA: a cancer journal for clinicians, 2011-01, Vol.61 (1), p.31

Language

English

Formats

Publication information

Publisher

Atlanta: Wiley Subscription Services, Inc

More information

Scope and Contents

Contents

Poly(ADP-ribose) polymerase (PARP) is an attractive antitumor target because of its vital role in DNA repair. The homologous recombination (HR) DNA repair pathway is critical for the repair of DNA double-strand breaks and HR deficiency leads to a dependency on error-prone DNA repair mechanisms, with consequent genomic instability and oncogenesis. T...

Alternative Titles

Full title

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_851268774

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_851268774

Other Identifiers

ISSN

0007-9235

E-ISSN

1542-4863

DOI

10.3322/caac.20095

How to access this item